Q4 2018 Bristol-Myers Squibb Co Earnings Call Transcript
Good day, and welcome to the Bristol-Myers Squibb 2018 Fourth Quarter Results Conference Call. Today's conference is being recorded.
At this time, I would like to turn the conference over to Mr. John Elicker, Senior Vice President, Public Affairs and Investor Relations. Please go ahead, sir.
Thank you, Greg, and good morning, everyone, and thanks for joining the call today. We do have a lot to discuss, including the quarter, our full year results, 2019 outlook as well as some additional perspectives on our announced acquisition of Celgene. We will be using a slide deck today, so we did e-mail it to you about 15 minutes ago. The slides are also available on our website.
Joining me today with prepared remarks are Giovanni Caforio, our Chairman and CEO; Charlie Bancroft, our CFO; and Chris Boerner, our Chief Commercial Officer. Tom Lynch is our Chief Scientific Officer, will also be here for Q&A. You'll see on Slides 2 and 3 of today's presentation our legal
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |